Recent evidence suggests that tumor-killing T cells and anti-PD-L1 antibodies induce ferroptosis in tumor cells, while ferroptosis inhibitors diminish the anticancer effectiveness of these agents (14). This evidence concerns the gene CD274 and neoplasm.